These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25500600)
1. Pharmacologic management of adult breakthrough cancer pain. Doulton B Can Fam Physician; 2014 Dec; 60(12):1111-4, e585-9. PubMed ID: 25500600 [No Abstract] [Full Text] [Related]
2. Use of oral formulations of fentanyl for breakthrough cancer pain. Handsaker S; Dempsey L; Fabby C Int J Palliat Nurs; 2015 Apr; 21(4):168, 170-2. PubMed ID: 25901588 [No Abstract] [Full Text] [Related]
3. Fentanyl pectin nasal spray for breakthrough cancer pain. Torres LM; Trinidad JM; Calderón E; Benitez D; Perelman M Int J Palliat Nurs; 2015 Mar; 21(3):114-6. PubMed ID: 25815759 [No Abstract] [Full Text] [Related]
10. WITHDRAWN: Opioids for the management of breakthrough pain in cancer patients. Zeppetella G; Davies AN Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD004311. PubMed ID: 26275024 [TBL] [Abstract][Full Text] [Related]
11. [Fentanyl: fast and furious?]. Meissner W; Sabatowski R Anaesthesist; 2013 Jun; 62(6):429-30. PubMed ID: 23748418 [No Abstract] [Full Text] [Related]
12. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose. Mercadante S; Ferrera P; Adile C; Casuccio A J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977 [TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer. Gombert-Handoko KB Clin Ther; 2014 Nov; 36(11):1704. PubMed ID: 25048312 [No Abstract] [Full Text] [Related]
14. Clinical and pharmacokinetic considerations of novel formulations of fentanyl for breakthrough cancer pain. Chen C; Gupta A Pain Manag; 2014; 4(5):339-50. PubMed ID: 25350074 [TBL] [Abstract][Full Text] [Related]
15. [Pregabalin combined with intrathecal sufentanil infusion for breakthrough pain in patients with bone metastases]. Cao Q; Huang D; Xu H; Wu L; Gu S Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Apr; 39(4):384-8. PubMed ID: 24820281 [TBL] [Abstract][Full Text] [Related]
16. Fentanyl for breakthrough cancer pain: where are we? Meriggi F; Zaniboni A Rev Recent Clin Trials; 2013 Mar; 8(1):42-7. PubMed ID: 23259417 [TBL] [Abstract][Full Text] [Related]
17. The role of rapid onset fentanyl products in the management of breakthrough pain in cancer patients. Brząkała J; Leppert W Pharmacol Rep; 2019 Jun; 71(3):438-442. PubMed ID: 31003154 [TBL] [Abstract][Full Text] [Related]
18. Patient satisfaction with intranasal fentanyl for breakthrough pain. Veldhorst-Janssen NM; Fiddelers AA; Zandstra H; Kessels AG; Zandstra H; Marcus MA; Neef C; van der Kuy PH J Palliat Med; 2012 Jun; 15(6):631-2. PubMed ID: 22656053 [No Abstract] [Full Text] [Related]
19. Breakthrough Cancer Pain: A Systematic Review of Pharmacologic Management . Brant JM; Rodgers BB; Gallagher E; Sundaramurthi T Clin J Oncol Nurs; 2017 Jun; 21(3 Suppl):71-80. PubMed ID: 28524907 [TBL] [Abstract][Full Text] [Related]
20. Trial design for breakthrough pain: is it ethical to have a placebo in a trial? Davis MP; Bruera E Clin Ther; 2014 May; 36(5):814-5. PubMed ID: 24726089 [No Abstract] [Full Text] [Related] [Next] [New Search]